0000899243-20-002041.txt : 20200127
0000899243-20-002041.hdr.sgml : 20200127
20200127163127
ACCESSION NUMBER: 0000899243-20-002041
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200123
FILED AS OF DATE: 20200127
DATE AS OF CHANGE: 20200127
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stuart Bryan
CENTRAL INDEX KEY: 0001619846
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38978
FILM NUMBER: 20549951
MAIL ADDRESS:
STREET 1: C/O CIVITAS THERAPEUTICS, INC.
STREET 2: 190 EVERETT AVENUE
CITY: CHELSEA
STATE: MA
ZIP: 02150
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fulcrum Therapeutics, Inc.
CENTRAL INDEX KEY: 0001680581
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474839948
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-651-8851
MAIL ADDRESS:
STREET 1: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-01-23
0
0001680581
Fulcrum Therapeutics, Inc.
FULC
0001619846
Stuart Bryan
C/O FULCRUM THERAPEUTICS, INC.
26 LANDSDOWNE STREET
CAMBRIDGE
MA
02139
0
1
0
0
Chief Operating Officer
Stock Option (right to buy)
16.87
2020-01-23
4
A
0
105000
0.00
A
2030-01-22
Common Stock
105000
105000
D
This option was granted on January 23, 2020 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2020, subject to continued service.
/s/ Peter Thomson, as attorney-in-fact for Bryan Stuart
2020-01-27